---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-052249"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2024-12-27T23:59:59+00:00"
generated_at: "2026-05-28T22:59:40.229634+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lixte Biotechnology VP and COO Eric Forman resigns effective Dec 31, 2024

## Summary
- Eric Forman resigned as VP and COO of Lixte Biotechnology Holdings, effective December 31, 2024.
- Resignation is for personal reasons; no disagreement with company operations, policies, or practices.
- Employment agreement dated July 15, 2020 (amended Aug 12, 2020 and Nov 6, 2022) terminates on Dec 31, 2024.
- No replacement or interim appointment has been announced.

## SEC filing metadata
- accession: 0001493152-24-052249
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2024-12-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315224052249/0001493152-24-052249-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315224052249/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-052249
- JSON: https://secwatch.observer/filing/0001493152-24-052249.json
- Plain text: https://secwatch.observer/filing/0001493152-24-052249.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.